HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying Cheng Selected Research

ferristatin II

1/2022Ferristatin II, an Iron Uptake Inhibitor, Exerts Neuroprotection against Traumatic Brain Injury via Suppressing Ferroptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying Cheng Research Topics

Disease

106Neoplasms (Cancer)
07/2022 - 11/2007
70Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2022 - 05/2012
33Disease Progression
12/2022 - 05/2012
30Neoplasm Metastasis (Metastasis)
11/2022 - 12/2008
25Lung Neoplasms (Lung Cancer)
06/2022 - 04/2014
24Hypertension (High Blood Pressure)
10/2022 - 05/2005
24Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2022 - 05/2014
23Inflammation (Inflammations)
06/2022 - 08/2004
20Colorectal Neoplasms (Colorectal Cancer)
10/2021 - 10/2012
18Infections
05/2022 - 11/2004
14Hepatocellular Carcinoma (Hepatoma)
01/2022 - 09/2013
12Diarrhea
01/2022 - 01/2017
12Breast Neoplasms (Breast Cancer)
01/2022 - 07/2010
12Adenocarcinoma of Lung
10/2021 - 07/2013
12Stomach Neoplasms (Stomach Cancer)
05/2021 - 12/2008
11Type 2 Diabetes Mellitus (MODY)
03/2022 - 01/2019
10Exanthema (Rash)
11/2022 - 05/2012
9Reperfusion Injury
06/2022 - 08/2004
9Adenocarcinoma
01/2021 - 02/2005
8Brain Neoplasms (Brain Tumor)
01/2022 - 01/2017
8Carcinoma (Carcinomatosis)
10/2021 - 12/2008
7Fibrosis (Cirrhosis)
02/2022 - 01/2018
7Hypoxia (Hypoxemia)
01/2022 - 05/2012
7Death (Near-Death Experience)
10/2021 - 12/2016
6Nausea
12/2022 - 04/2014
6Cholestasis
01/2022 - 01/2015
6Proteinuria
01/2021 - 01/2015
6Hand-Foot Syndrome
01/2021 - 12/2008
6Neutropenia
11/2020 - 04/2016
5Fatigue
10/2022 - 09/2014
5Thrombocytopenia (Thrombopenia)
02/2022 - 09/2014
5Body Weight (Weight, Body)
01/2022 - 12/2007
5Ischemia
01/2021 - 06/2008
5Pain (Aches)
05/2020 - 11/2008
5Lymphoma (Lymphomas)
01/2020 - 01/2013
4Ovarian Neoplasms (Ovarian Cancer)
12/2022 - 01/2021
4Anemia
12/2022 - 01/2019
4Cardiovascular Diseases (Cardiovascular Disease)
06/2022 - 06/2017
4Glioblastoma (Glioblastoma Multiforme)
03/2022 - 01/2018
4Carcinogenesis
01/2022 - 04/2011
4Diabetic Nephropathies (Diabetic Nephropathy)
11/2021 - 01/2018

Drug/Important Bio-Agent (IBA)

35Proteins (Proteins, Gene)FDA Link
02/2022 - 02/2005
26Pharmaceutical PreparationsIBA
05/2022 - 02/2005
25Tyrosine Kinase InhibitorsIBA
11/2022 - 06/2013
23ErbB Receptors (EGF Receptor)IBA
11/2022 - 06/2013
20anlotinibIBA
10/2022 - 01/2018
18Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2014
18Cisplatin (Platino)FDA LinkGeneric
11/2021 - 12/2008
17Gefitinib (Iressa)FDA Link
11/2022 - 05/2012
16MicroRNAs (MicroRNA)IBA
01/2022 - 04/2011
15Messenger RNA (mRNA)IBA
01/2022 - 11/2004
14PlatinumIBA
12/2022 - 05/2012
11Alanine Transaminase (SGPT)IBA
11/2022 - 12/2008
10Therapeutic UsesIBA
06/2022 - 11/2011
9Immune Checkpoint InhibitorsIBA
03/2022 - 09/2017
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 02/2005
9B7-H1 AntigenIBA
01/2022 - 11/2017
9Docetaxel (Taxotere)FDA Link
12/2021 - 07/2010
9LipidsIBA
01/2021 - 02/2012
9Fluorouracil (Carac)FDA LinkGeneric
01/2019 - 02/2005
8CytokinesIBA
05/2022 - 11/2011
8NivolumabIBA
04/2022 - 10/2017
8Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2009
8dicarboxydine (DCD)IBA
10/2021 - 12/2016
8Capecitabine (Xeloda)FDA Link
01/2021 - 12/2008
7Biological ProductsIBA
01/2022 - 02/2013
7Transcription Factors (Transcription Factor)IBA
07/2020 - 01/2015
6Aspartate Aminotransferases (Aspartate Transaminase)IBA
11/2022 - 06/2015
6camrelizumabIBA
06/2022 - 01/2021
6Insulin (Novolin)FDA Link
03/2022 - 05/2007
6Blood Glucose (Blood Sugar)IBA
03/2022 - 12/2007
6empagliflozinIBA
01/2022 - 01/2019
6Carboplatin (JM8)FDA LinkGeneric
01/2022 - 09/2014
6Bile Acids and Salts (Bile Acids)IBA
01/2022 - 01/2015
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 01/2014
6LipopolysaccharidesIBA
10/2021 - 10/2011
6Bevacizumab (Avastin)FDA Link
07/2021 - 03/2012
6apatinibIBA
01/2021 - 09/2013
6osimertinibIBA
01/2021 - 11/2018
6Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021 - 10/2012
6DNA (Deoxyribonucleic Acid)IBA
11/2019 - 10/2013
5LigandsIBA
07/2022 - 05/2014
5Angiotensin IIIBA
01/2022 - 09/2009
5AntigensIBA
01/2022 - 02/2013
5pembrolizumabIBA
11/2021 - 10/2017
5dacomitinibIBA
03/2021 - 11/2017
5Sorafenib (BAY 43-9006)FDA Link
01/2021 - 03/2014
5Pemetrexed (MTA)FDA Link
01/2021 - 09/2014
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 04/2016
5Paclitaxel (Taxol)FDA LinkGeneric
12/2019 - 09/2010
5GemcitabineFDA Link
01/2019 - 09/2014
4CollagenIBA
02/2022 - 01/2018
4Etoposide (VP 16)FDA LinkGeneric
01/2022 - 04/2016

Therapy/Procedure

80Therapeutics
11/2022 - 08/2003
77Drug Therapy (Chemotherapy)
10/2022 - 12/2008
12Immunotherapy
01/2022 - 06/2014
9Radiotherapy
09/2021 - 04/2014
5Liver Transplantation
10/2021 - 12/2016
5Transplantation
02/2021 - 08/2004
5Aftercare (After-Treatment)
01/2021 - 12/2014